ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party

INMACULADA CONCEPCIÓN HERRERA ARROYO2026-01-292026-01-29202310.3389/fimmu.2023.12830342-s2.0-85180670032https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37275ImmunologyImmunology and AllergyECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working partyresearch article